Morepen Laboratories Limited Stock: price and insider trades · India
Morepen Laboratories Limited: what insiders have been doing
Only a handful of insider records exist for Morepen Laboratories Limited, the last one from 22 September 2022, too few to describe a trend. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:414581465b3202a0ac60836ff3a3e2ee5b9bce8c
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:a733b1b22a568ec4d7c8b38db43af073a9b008d9
- 5,000,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:d9bc8fedd9fe4dbc37ebe812c9fb8f738bdc07a2
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:2b8c840f2a96f224126638a1c24f98eb3d273b2b
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:76435bd70e89cae75ba5d10f083d263201733f9e
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:15694126f91081f580865fd94704986074c9ac21
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:670186a8757c8cde0fdbb097595fe5737b75d9b2
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:eca92bd979e03fea2aeba49166afab925a37999a
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:1d965661cb945d3d0e50f29046db30aaf199e313
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:6c10a2f9821cf0964d6a51841755e038d17d6b46
- 3,500,000 shares@ ₹25.00100.0% of flowEquity SharesSEBI:b31a5e2edeb4b7e1f25efb6716b8d4d5a08b58cc
11 of 11 declarations
About Morepen Laboratories Limited
Morepen Laboratories Limited is an Indian company engaged in the manufacturing of pharmaceutical products and medical devices. It is listed on the Bombay Stock Exchange and focuses on innovation in the healthcare sector.
